Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety

Intravenous (IV) hydralazine, enalapril and labetalol are oftentimes used without indication for the treatment of asymptomatic hypertension in the hospital setting and have been shown to have substantial adverse effects that are associated with increased morbidity and mortality, as well as longer le...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Jacob, Salman, Alicja, Kumar, Sarwan, Gjeka, Rudin, Tegeltija, Vesna, Peterson, Daymon, Chams, Nour, Ross, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Quality Improvement Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887509/
https://www.ncbi.nlm.nih.gov/pubmed/31803850
http://dx.doi.org/10.1136/bmjoq-2019-000626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887509/
https://www.ncbi.nlm.nih.gov/pubmed/31803850
http://dx.doi.org/10.1136/bmjoq-2019-000626

Ejemplares similares